RecruitingNot ApplicableNCT04266418

The Evaluation of Banana Flower Stamens Extract on Prevention of Benign Prostatic Hyperplasia in Adults

Sponsor

TCI Co., Ltd.

Enrollment

50 participants

Start Date

Mar 1, 2023

Study Type

INTERVENTIONAL

Conditions

To assess the evaluation of banana flower stamens extract on prevention of benign prostatic hyperplasia in adults

Sex: MALEMin Age: 40 YearsMax Age: 80 Years

Male aged 40-80 years old
≤ IPSS score \<19
The subject did not take α-blocker or anticholinergic agents in the last 8 weeks. The subject did not take 5α-reductase inhibitor or androgen suppression agents in the last 16 weeks (depending on medical history).
The subject isn't diagnosed with cancer
The subject is able to read and finish the information on the questionnaire.
The subject must read and sign the informed consent form after the study has been fully explained.

The subject has a history of epilepsy or convulsions, liver and kidney disease, cancer, endocrine disease, mental illness, alcohol or drug abuse, and other major organic diseases (depending on medical history).
The lower urinary tract urination symptoms of the subject are not related to prostatic hypertrophy (depending on medical history).
Residual urine volume \> 250 mL (depending on medical history)
Subjects have had pelvic radiation therapy or pelvic surgery (including prostate or bladder surgery, but those who only have had a prostate slice can participate in the trial).
Subjects have taken sexual hormone preparations including LHRH agonists, anti-androgens, feminine, or Penta-reductase inhibitors (Proscar and Avodart) 16 weeks prior to the trial.
Subjects have participated in other clinical trials 12 weeks prior to the trial.

Interested in this trial?

Get notified about updates and connect with the research team.